Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).
Through his public-benefit corporation Star Syringe, Koska first needed to embark on a public policy and advocacy campaign to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback